Home sales rise 1.5% in September as mortgage rates dip
Home sales increased 1.5% in September as mortgage rates dipped, according to the National Association of Realtors.
The group said September’s 1.5% increase in existing-home sales put sales on a seasonally adjusted annual rate of 4.06 million in September. It also reported a 1.3% increase in unsold inventory to 1.55 million units, equal to 4.6 months’ supply. Six months worth of supply is generally considered a balanced market.
“As anticipated, falling mortgage rates are lifting home sales,” NAR Chief Economist Dr. Lawrence Yun said. “Improving housing affordability is also contributing to the increase in sales.”
Year-over-year, existing home sales were up 4.1%. Prices were up as well.
Existing home sales gained 2.1%, pushing the median existing-home sales price to $415,200. That’s the 27th consecutive month of year-over-year price increases.
“Inventory is matching a five-year high, though it remains below pre-COVID levels,” Yun said. “Many homeowners are financially comfortable, resulting in very few distressed properties and forced sales. Home prices continue to rise in most parts of the country, further contributing to overall household wealth.”
The average 30-year fixed-rate mortgage in September was 6.35%, according to Freddie Mac. That’s down from 6.59% in August and up from 6.18% one year ago.
Latest News Stories
Cartel bounties on ICE agents similar to bounties placed in Texas communities for years
Trump slices China fentanyl tariff in half following meeting with Xi
White Oak Pastor Mike Martin Guest Speaker at Rotary
ISP Arrest Man Charged with Aggrivated DUI and Reckless Homicide in Westfield Crash
A Recipe for Fun: Fifth Grade Math Gets Hands-On
Trump orders Department of War to begin testing nuclear weapons
WATCH: Tax proposals draw questions from Pritzker and GOP state rep
Illinois quick hits: Former sheriff’s deputy guilty in Massey murder; appeals court intervenes in Bavino case
WATCH: Warnings of higher IL property taxes heard as pension bill advances
Top-selling automaker confirms U.S. investment, but no details yet
Fentanyl poised to take center stage during Trump, Xi meeting
‘Outrageous’: Lawmakers bash Biden admin for targeting, surveilling 156 Republicans